• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Debated Role of Ovarian Protection With Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Women With Cancer.

作者信息

Lambertini Matteo, Falcone Tommaso, Unger Joseph M, Phillips Kelly-Anne, Del Mastro Lucia, Moore Halle C F

机构信息

Matteo Lambertini, Breast Adjuvant Study Team Data Centre, Institut Jules Bordet, and Université Libre de Bruxelles, Brussels, Belgium; Tommaso Falcone, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH; Joseph M. Unger, Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA; Kelly-Anne Phillips, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Lucia Del Mastro, Istituto di Ricovero e Cura a Carattere Scientifico-Azienda Ospedaliera Universitaria San Martino-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy; and Halle C.F. Moore, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH.

出版信息

J Clin Oncol. 2017 Mar;35(7):804-805. doi: 10.1200/JCO.2016.69.2582. Epub 2016 Nov 28.

DOI:10.1200/JCO.2016.69.2582
PMID:27893335
Abstract
摘要

相似文献

1
Debated Role of Ovarian Protection With Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Women With Cancer.促性腺激素释放激素激动剂在化疗期间对卵巢的保护作用在癌症女性保留卵巢功能和生育能力方面的争议角色
J Clin Oncol. 2017 Mar;35(7):804-805. doi: 10.1200/JCO.2016.69.2582. Epub 2016 Nov 28.
2
Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors.化疗期间促性腺激素释放激素激动剂联合治疗可能提高幸存者的妊娠率。
Oncologist. 2015 Nov;20(11):1283-9. doi: 10.1634/theoncologist.2015-0223. Epub 2015 Oct 13.
3
No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.没有证据表明促性腺激素释放激素激动剂可改善化疗后淋巴瘤幸存者的卵巢功能和生育能力：一项前瞻性随机试验的最终长期报告。
J Clin Oncol. 2016 Aug 1;34(22):2568-74. doi: 10.1200/JCO.2015.65.8864. Epub 2016 May 23.
4
Preservation of gonadal function in women undergoing chemotherapy: a review of the potential role for gonadotropin-releasing hormone agonists.化疗女性性腺功能的保护：促性腺激素释放激素激动剂潜在作用的综述
Am J Obstet Gynecol. 2016 Oct;215(4):415-22. doi: 10.1016/j.ajog.2016.06.053. Epub 2016 Jul 13.
5
Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists.选择化疗方案时保护生育能力——促性腺激素释放激素激动剂的作用
Expert Opin Pharmacother. 2015 May;16(7):1009-20. doi: 10.1517/14656566.2015.1031654. Epub 2015 Mar 31.
6
Fertility preservation in women with breast cancer undergoing adjuvant chemotherapy: a systematic review.乳腺癌辅助化疗患者的生育力保存：系统评价。
Fertil Steril. 2010 Jun;94(1):138-43. doi: 10.1016/j.fertnstert.2009.02.055. Epub 2009 Apr 1.
7
Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.促性腺激素释放激素激动剂在早期乳腺癌化疗的绝经前妇女中保存卵巢功能的作用：系统评价和荟萃分析。
JAMA Oncol. 2016 Jan;2(1):65-73. doi: 10.1001/jamaoncol.2015.3251.
8
Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.促性腺激素释放激素激动剂在癌症化疗中对卵巢的保护作用：系统评价和荟萃分析。
Ultrasound Obstet Gynecol. 2018 Jan;51(1):77-86. doi: 10.1002/uog.18934. Epub 2017 Dec 1.
9
Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology.化疗期间的卵巢临时抑制以保护乳腺癌患者的卵巢功能和生育能力：意大利肿瘤医学协会进行证据评估和推荐的 GRADE 方法。
Eur J Cancer. 2017 Jan;71:25-33. doi: 10.1016/j.ejca.2016.10.034. Epub 2016 Dec 9.
10
Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?促性腺激素释放激素激动剂在生育力保存中的应用：揭开谜团？
Hum Reprod. 2015 May;30(5):1089-101. doi: 10.1093/humrep/dev037. Epub 2015 Mar 21.

引用本文的文献

1
AMH protects the ovary from doxorubicin by regulating cell fate and the response to DNA damage.抗苗勒管激素通过调节细胞命运和对DNA损伤的反应来保护卵巢免受阿霉素的影响。
Proc Natl Acad Sci U S A. 2025 Feb 4;122(5):e2414734122. doi: 10.1073/pnas.2414734122. Epub 2025 Jan 28.
2
Fertility and Pregnancy-Related Issues in Young Carriers With Breast Cancer.年轻乳腺癌携带者的生育及妊娠相关问题
Breast Cancer (Auckl). 2024 Jun 14;18:11782234241261429. doi: 10.1177/11782234241261429. eCollection 2024.
3
Research progress on the prevention and treatment of chemotherapy-induced ovarian damage.
化疗诱导的卵巢损伤防治的研究进展。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 May 10;53(3):288-296. doi: 10.3724/zdxbyxb-2023-0495.
4
Gender-specific aspects related to type of fertility preservation strategies and access to fertility care.与生育力保存策略类型和获得生育力护理相关的性别特定方面。
ESMO Open. 2020 Oct;5(Suppl 4):e000771. doi: 10.1136/esmoopen-2020-000771.
5
Burning Questions in the Oncofertility Counseling of Young Breast Cancer Patients.年轻乳腺癌患者肿瘤生育咨询中的热点问题
Breast Cancer (Auckl). 2020 Sep 4;14:1178223420954179. doi: 10.1177/1178223420954179. eCollection 2020.
6
Preserving fertility in female patients with hematological malignancies: the key points.血液系统恶性肿瘤女性患者的生育力保护：要点
Expert Rev Hematol. 2019 Jun;12(6):375-377. doi: 10.1080/17474086.2019.1613150. Epub 2019 May 6.
7
Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?乳腺癌患者的卵巢功能与生育力保护：是否应对所有接受化疗的绝经前患者使用促性腺激素释放激素激动剂？
Clin Med Insights Reprod Health. 2019 Mar 9;13:1179558119828393. doi: 10.1177/1179558119828393. eCollection 2019.
8
Fertility preservation in ovarian tumours.卵巢肿瘤中的生育力保存
Ecancermedicalscience. 2018 Dec 6;12:885. doi: 10.3332/ecancer.2018.885. eCollection 2018.
9
Long-term comparisons of the efficacy, safety, and pregnancy outcomes of adjuvant tamoxifen plus ovarian function suppression in premenopausal Han and Zhuang Chinese patients with hormone receptor-positive early breast cancer.绝经前汉族和壮族激素受体阳性早期乳腺癌患者中，他莫昔芬辅助治疗联合卵巢功能抑制的疗效、安全性及妊娠结局的长期比较
J Int Med Res. 2019 Feb;47(2):641-652. doi: 10.1177/0300060518807100. Epub 2018 Oct 25.
10
Preservation of gonadal function in women undergoing chemotherapy: a systematic review and meta-analysis of the potential role for gonadotropin-releasing hormone agonists.化疗女性性腺功能保护：促性腺激素释放激素激动剂潜在作用的系统评价和荟萃分析。
J Assist Reprod Genet. 2018 Apr;35(4):571-581. doi: 10.1007/s10815-018-1128-2. Epub 2018 Feb 22.